Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 118, Issue 48, Pages -Publisher
NATL ACAD SCIENCES
DOI: 10.1073/pnas.2108776118
Keywords
G protein-coupled receptors; cell signaling; receptor dimerization
Categories
Funding
- Swiss National Science Foundation [CRSII2_160805]
- National Centre of Competence in Research (NCCR) Molecular Systems Engineering [51NF40-182895]
- Swiss National Science Foundation (SNF) [CRSII2_160805] Funding Source: Swiss National Science Foundation (SNF)
Ask authors/readers for more resources
This study demonstrates that using rigid oligoproline backbones can develop ligands with biased GPCR signaling, and stabilizing GPCR dimers by fixing the distance between their recognition motifs can expand the space for medicinal chemistry.
G protein-coupled receptors (GPCRs) are one of the most important drug-target classes in pharmaceutical industry. Their diversity in signaling, which can be modulated with drugs, permits the design of more effective and better-tolerated therapeutics. In this work, we have used rigid oligoproline backbones to generate bivalent ligands for the gastrin-releasing peptide receptor (GRPR) with a fixed distance between their recognition motifs. This allows the stabilization of GPCR dimers irrespective of their physiological occurrence and relevance, thus expanding the space for medicinal chemistry. Specifically, we observed that compounds presenting agonists or antagonists at 20- and 30-A distance induce GRPR dimerization. Furthermore, we found that 1) compounds with two agonists at 20- and 30-angstrom distance that induce dimer formation show bias toward Gq efficacy, 2) dimers with 20- and 30-angstrom distance have different potencies toward beta-arrestin-1 and beta-arrestin-2, and 3) the divalent agonistic ligand with 10-angstrom distance specifically reduces Gq potency without affecting beta-arrestin recruitment, pointing toward an allosteric effect. In summary, we show that rigid oligoproline backbones represent a tool to develop ligands with biased GPCR signaling.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available